FDA Approval Summary: Vorasidenib for <i>IDH</i> -Mutant Grade 2 Astrocytoma or Oligodendroglioma Following SurgeryMichael I. Barbato, Nicole Drezner, Yuching Yang et al.|Clinical Cancer Research|2025Cited by 9
Intervention of natural products targeting novel mechanisms after myocardial infarctionGuang‐Jie Tai, Ming Xu, Jiancheng Yang et al.|Chinese Journal of Natural Medicines|2025Cited by 1